MetaCap

GRI Bio Insider Trades

NASDAQ: GRIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.120.00 (0.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

GRI Bio insider activity

No GRI Bio insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Hertz Walter Marc (Chief Executive Officer) reporting a transaction in 385,510 shares on Apr 21, 2023. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GRI's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

GRI insider transactions

GRI Bio insider transactions
DateInsiderTypeSharesValueFiling
Apr 21, 2023Chaturvedi VipinChief Scientific OfficerAward172,189—Form 4
Apr 21, 2023Agro AlbertChief Medical OfficerAward172,189—Form 4
Apr 21, 2023Hertz Walter MarcChief Executive OfficerAward385,510—Form 4
Dec 13, 2022Thorell MarellaDirectorother28,517—Form 4
Jul 1, 2022Thorell MarellaDirectorAward38,023—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related